I agree with you on SP & it’s looking like the dots are starting to connect now in the USA at least, after FDA approval of Canafliglozin for CKD indication. I could be wrong in summising this, but a lot of “coincidence” there, particularly with Janssen collaboration with AKF to “build on” their current screening programme for CKD & a focus on diabetes.
Have a great day all
PIQ Price at posting:
32.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)